Atlas Trials

Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria

Clinical trial NCT02289755 · COMPLETED

Trial details

NCT number
NCT02289755
Sponsor
Allena Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HyperoxaluriaNephrolithiasis
Start date
2014-09-01
Primary completion
2015-01-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.